The first AdaptHealth trade was made in Q2 2021.
Since then Ray Dalio bought shares five more times and sold shares on ten occasions. The investor completely sold their stake between Q4 2023 and Q1 2025.
Avg closing price
Price range
Sold -11.7 Thousand shares
Q1 2025
Avg closing price
$10.05
Price range
$8.45
-
$11.38
Sold 71.3% shares (-29.1 Thousand shares)
Q4 2024
Avg closing price
$10.13
Price range
$9.18
-
$11.00
Sold 50.5% shares (-41.5 Thousand shares)
Q3 2024
Avg closing price
$10.62
Price range
$8.66
-
$11.53
Sold 6.6% shares (-5.86 Thousand shares)
Q2 2024
Avg closing price
$10.16
Price range
$9.19
-
$11.60
Sold 14.3% shares (-14.7 Thousand shares)
Q1 2024
Avg closing price
$8.49
Price range
$6.64
-
$11.51
Sold 6.8% shares (-7.49 Thousand shares)
Q4 2023
Avg closing price
$7.88
Price range
$6.49
-
$9.20
Increased shares by 22.1% (+19.9 Thousand shares)
Q3 2023
Avg closing price
$11.99
Price range
$8.60
-
$14.77
Increased shares by 2.0% (+1.73 Thousand shares)
Q2 2023
Avg closing price
$11.14
Price range
$9.43
-
$12.52
Increased shares by 5.9% (+4.9 Thousand shares)
Q1 2023
Avg closing price
$18.40
Price range
$12.43
-
$22.73
Sold 19.7% shares (-20.5 Thousand shares)
Q4 2022
Avg closing price
$21.14
Price range
$19.02
-
$23.00
Sold 1.5% shares (-1.59 Thousand shares)
Q3 2022
Avg closing price
$20.55
Price range
$17.38
-
$25.72
Increased shares by 9.4% (+9.05 Thousand shares)
Q2 2022
Avg closing price
$16.24
Price range
$11.43
-
$19.27
Increased shares by 23.1% (+18.2 Thousand shares)
Q1 2022